Stay updated on the most recent developments in Symeres.
While working in big pharma, Dr. Chris Teleha spent years working with CROs in the development […]
COVID-19 has changed how we interact with people and has forced us to re-evaluate how we […]
The timely availability of high-quality APIs accelerates further investigation by our clients. To meet these pressing API needs, Symeres enables a route-scouting investigation for the API of interest.
This spring, Symeres Prague was audited by the national control authority SÚKL. After this audit, our […]
Earlier this year, our client TOLREMO therapeutics nominated the clinical candidate for a chemical series that […]
A key goal of clinical trials is to evaluate whether the potential new drug reaches its […]
Paris (France) – May 25th 2021 We are pleased to let you know that Keensight Capital, […]
Organic chemistry at Symeres has been proactively accommodating recent developments in drug discovery. Today, we are […]
Ton’s days start with a 20 km bike ride from his farm in Drenthe to Symeres […]